Dolby Laboratories (DLB) Long-Term Deferred Tax (2009 - 2026)

Dolby Laboratories (DLB) has reported Long-Term Deferred Tax for 18 consecutive years, with $213.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Deferred Tax fell 6.77% year-over-year to $213.2 million; the trailing twelve-month figure through Jun 2026 stood at $213.2 million (down 6.77% YoY), and the FY2025 full-year result was $214.4 million, down 2.46% from the prior year.
• Long-Term Deferred Tax improved to $213.2 million in Q2 2026 per DLB's latest filing, from $209.3 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $228.6 million in Q2 2025 and bottomed at $175.2 million in Q2 2022.
• Historically, Long-Term Deferred Tax has averaged $207.5 million across 5 years, with a median of $209.5 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Long-Term Deferred Tax rose 29.28% in 2022, then dropped 6.77% in 2026.
• Over 5 years, Long-Term Deferred Tax stood at $192.2 million in 2022, then grew by 7.54% to $206.7 million in 2023, then increased by 9.85% to $227.0 million in 2024, then slipped by 5.58% to $214.3 million in 2025, then dropped by 0.55% to $213.2 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $213.2 million, $209.3 million, and $214.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.